Recursion Pharmaceuticals, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $3.2 Billion | 1/18 | RXRX $3.2B |
DAWN $1.2B |
SANA $634.1M |
RLAY $629.4M |
ABSI $573.1M |
INZY $86.7M |
ABOS $82.3M |
XFOR $80.2M |
IMMX $54.7M |
FRLN $28.3M |
AFMD $15.2M |
OCEA $5.9M |
CNSP $5.7M |
AVRO $5.2M |
ENVB $3.0M |
HEPA $2.1M |
CWBR $1.2M |
EFTR $0 |
Gross Margin | 54% | 5/18 | AFMD 100% |
FRLN 100% |
ABSI 100% |
DAWN 92% |
RXRX 54% |
XFOR 18% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
CNSP 0% |
RLAY 0% |
INZY 0% |
SANA 0% |
OCEA 0% |
EFTR 0% |
ENVB 0% |
ABOS 0% |
IMMX 0% |
Profit Margin | -100% | 15/18 | XFOR 100% |
DAWN 100% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
CNSP 0% |
RLAY 0% |
INZY 0% |
SANA 0% |
OCEA 0% |
EFTR 0% |
ENVB 0% |
ABOS 0% |
IMMX 0% |
RXRX -100% |
AFMD -100% |
FRLN -100% |
ABSI -100% |
EBITDA margin | -377% | 14/18 | DAWN 148% |
CWBR -100% |
AVRO -100% |
HEPA -100% |
CNSP -100% |
RLAY -100% |
INZY -100% |
SANA -100% |
OCEA -100% |
EFTR -100% |
ENVB -100% |
ABOS -100% |
IMMX -100% |
RXRX -377% |
ABSI -1404% |
XFOR -5986% |
AFMD -9320% |
FRLN -231180% |
Quarterly Revenue | $26.1 Million | 1/18 | RXRX $26.1M |
DAWN $20.1M |
ABSI $1.7M |
XFOR $563,000 |
AFMD $170,330 |
FRLN $5,000 |
CWBR $0 |
AVRO $0 |
HEPA $0 |
CNSP $0 |
RLAY $0 |
INZY $0 |
SANA $0 |
OCEA $0 |
EFTR $0 |
ENVB $0 |
ABOS $0 |
IMMX $0 |
Quarterly Earnings | -$95.7 Million | 18/18 | XFOR $90.8M |
DAWN $37.0M |
ENVB -$2.1M |
CWBR -$4.3M |
HEPA -$4.9M |
OCEA -$5.5M |
CNSP -$5.6M |
AVRO -$6.8M |
IMMX -$7.1M |
EFTR -$8.8M |
FRLN -$12.1M |
AFMD -$16.6M |
INZY -$24.6M |
ABSI -$27.4M |
ABOS -$29.8M |
SANA -$59.9M |
RLAY -$88.1M |
RXRX -$95.7M |
Quarterly Free Cash Flow | -$60.8 Million | 17/18 | OCEA -$885,000 |
ENVB -$927,073 |
CWBR -$1.8M |
HEPA -$2.5M |
IMMX -$4.3M |
DAWN -$5.0M |
CNSP -$6.8M |
EFTR -$7.3M |
AVRO -$7.6M |
FRLN -$8.7M |
AFMD -$12.2M |
ABSI -$20.8M |
INZY -$24.5M |
ABOS -$24.6M |
XFOR -$30.4M |
SANA -$55.9M |
RXRX -$60.8M |
RLAY -$75.3M |
Trailing 4 Quarters Revenue | $65.2 Million | 1/18 | RXRX $65.2M |
DAWN $28.8M |
RLAY $10.0M |
ABSI $4.2M |
AFMD $963,736 |
FRLN $622,000 |
XFOR $563,000 |
CWBR $0 |
AVRO $0 |
HEPA $0 |
CNSP $0 |
INZY $0 |
SANA $0 |
OCEA $0 |
EFTR $0 |
ENVB $0 |
ABOS $0 |
IMMX $0 |
Trailing 4 Quarters Earnings | -$377.6 Million | 18/18 | RXRX $26.1M |
DAWN $20.1M |
ABSI $1.7M |
XFOR $563,000 |
AFMD $170,330 |
FRLN $5,000 |
CWBR -$0 |
AVRO -$0 |
HEPA -$0 |
CNSP -$0 |
RLAY -$0 |
INZY -$0 |
SANA -$0 |
OCEA -$0 |
EFTR -$0 |
ENVB -$0 |
ABOS -$0 |
IMMX -$0 |
Quarterly Earnings Growth | -3% | 10/18 | XFOR 263% |
DAWN 180% |
AVRO 72% |
OCEA 61% |
HEPA 54% |
AFMD 38% |
ENVB 26% |
FRLN 19% |
EFTR 10% |
RXRX -3% |
CNSP -24% |
ABSI -25% |
RLAY -34% |
INZY -48% |
CWBR -59% |
IMMX -67% |
ABOS -130% |
SANA -6190% |
Annual Earnings Growth | -17% | 14/18 | XFOR 108% |
HEPA 57% |
ENVB 55% |
OCEA 50% |
DAWN 50% |
FRLN 43% |
AFMD 38% |
ABSI 34% |
EFTR 12% |
SANA 10% |
RLAY 4% |
CWBR 1% |
CNSP -3% |
RXRX -17% |
IMMX -46% |
INZY -52% |
AVRO -59% |
ABOS -71% |
Quarterly Revenue Growth | 158% | 1/18 | RXRX 158% |
ABSI 129% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
XFOR 0% |
CNSP 0% |
INZY 0% |
FRLN 0% |
SANA 0% |
OCEA 0% |
DAWN 0% |
EFTR 0% |
ENVB 0% |
ABOS 0% |
IMMX 0% |
AFMD -92% |
RLAY -100% |
Annual Revenue Growth | 51% | 1/18 | RXRX 51% |
CWBR 0% |
AVRO 0% |
HEPA 0% |
XFOR 0% |
CNSP 0% |
INZY 0% |
FRLN 0% |
SANA 0% |
OCEA 0% |
DAWN 0% |
EFTR 0% |
ENVB 0% |
ABOS 0% |
IMMX 0% |
RLAY -61% |
ABSI -61% |
AFMD -86% |
Cash On Hand | $427.6 Million | 1/18 | RXRX $427.6M |
DAWN $422.8M |
RLAY $152.4M |
XFOR $147.2M |
SANA $127.0M |
AVRO $90.8M |
ABSI $38.2M |
ABOS $33.2M |
FRLN $29.5M |
INZY $24.6M |
IMMX $19.7M |
EFTR $15.5M |
AFMD $8.1M |
CNSP $7.0M |
CWBR $6.2M |
ENVB $3.1M |
HEPA $1.5M |
OCEA -$0 |
Short Term Debt | $16.5 Million | 2/18 | EFTR $19.0M |
RXRX $16.5M |
OCEA $12.8M |
SANA $10.6M |
AFMD $7.6M |
RLAY $5.5M |
ABSI $5.0M |
INZY $4.6M |
FRLN $2.3M |
HEPA $2.2M |
XFOR $1.2M |
AVRO $224,000 |
ABOS $129,000 |
DAWN $77,000 |
IMMX $62,715 |
CNSP $31,187 |
CWBR -$0 |
ENVB -$0 |
Long Term Debt | $74.2 Million | 3/18 | SANA $85.5M |
XFOR $75.0M |
RXRX $74.2M |
RLAY $44.3M |
INZY $42.2M |
ABOS $29.9M |
ABSI $7.0M |
AFMD $6.6M |
DAWN $2.5M |
FRLN $1.7M |
IMMX $1.0M |
EFTR $179,000 |
CWBR $0 |
AVRO $0 |
HEPA $0 |
CNSP $0 |
OCEA $0 |
ENVB $0 |
PE | -1.00 | 3/18 | XFOR 4.55 |
AVRO 0.17 |
RXRX -1.00 |
AFMD -1.00 |
CWBR -1.00 |
HEPA -1.00 |
CNSP -1.00 |
RLAY -1.00 |
INZY -1.00 |
FRLN -1.00 |
SANA -1.00 |
OCEA -1.00 |
DAWN -1.00 |
EFTR -1.00 |
ENVB -1.00 |
ABOS -1.00 |
ABSI -1.00 |
IMMX -1.00 |
PS | 49.10 | 4/18 | XFOR 142.37 |
ABSI 136.23 |
RLAY 62.90 |
RXRX 49.10 |
FRLN 45.47 |
DAWN 42.44 |
AFMD 14.38 |
CWBR -1.00 |
AVRO -1.00 |
HEPA -1.00 |
CNSP -1.00 |
INZY -1.00 |
SANA -1.00 |
OCEA -1.00 |
EFTR -1.00 |
ENVB -1.00 |
ABOS -1.00 |
IMMX -1.00 |
PB | 6.10 | 1/18 | RXRX 6.10 |
IMMX 3.12 |
ABSI 2.85 |
DAWN 2.20 |
SANA 2.17 |
CNSP 1.71 |
INZY 1.05 |
FRLN 0.94 |
XFOR 0.85 |
AFMD 0.81 |
ENVB 0.77 |
RLAY 0.75 |
ABOS 0.38 |
CWBR 0.13 |
AVRO 0.06 |
HEPA 0.00 |
OCEA 0.00 |
EFTR 0.00 |
PC | 7.48 | 2/18 | ABSI 15.01 |
RXRX 7.48 |
SANA 4.99 |
RLAY 4.13 |
INZY 3.53 |
DAWN 2.89 |
IMMX 2.78 |
ABOS 2.48 |
AFMD 1.87 |
HEPA 1.42 |
ENVB 0.98 |
FRLN 0.96 |
CNSP 0.82 |
XFOR 0.54 |
CWBR 0.19 |
AVRO 0.06 |
EFTR 0.00 |
OCEA -1.00 |
Liabilities to Equity | 0.38 | 9/18 | EFTR 31.81 |
AFMD 1.32 |
XFOR 1.23 |
CNSP 1.21 |
SANA 0.91 |
INZY 0.73 |
FRLN 0.64 |
IMMX 0.43 |
RXRX 0.38 |
CWBR 0.32 |
ABOS 0.23 |
ENVB 0.21 |
ABSI 0.17 |
RLAY 0.11 |
DAWN 0.08 |
AVRO 0.04 |
HEPA 0.00 |
OCEA 0.00 |
ROA | -0.52 | 7/18 | AVRO 33% | XFOR 8% | DAWN -15% | ABOS -31% | RLAY -37% | ABSI -42% | RXRX -52% | SANA -55% | INZY -67% | IMMX -87% | CWBR -99% | FRLN -101% | EFTR -128% | AFMD -192% | ENVB -206% | CNSP -230% | HEPA -611% | OCEA -2352% |
ROE | -0.72 | 9/18 | HEPA 5583% |
AVRO 34% |
OCEA 27% |
XFOR 19% |
DAWN -16% |
ABOS -38% |
RLAY -41% |
ABSI -49% |
RXRX -72% |
SANA -105% |
INZY -117% |
IMMX -125% |
CWBR -131% |
FRLN -166% |
ENVB -249% |
AFMD -447% |
CNSP -509% |
EFTR -4187% |
Current Ratio | 3.60 | 8/18 | AVRO 26.32 |
DAWN 13.25 |
RLAY 10.19 |
ABSI 6.94 |
ENVB 5.71 |
ABOS 5.36 |
CWBR 4.17 |
RXRX 3.60 |
IMMX 3.31 |
FRLN 2.57 |
INZY 2.37 |
SANA 2.10 |
CNSP 1.83 |
XFOR 1.81 |
AFMD 1.76 |
EFTR 1.03 |
HEPA 0.90 |
OCEA 0.01 |
Quick Ratio | 2.12 | 9/18 | XFOR 4.55 |
AVRO 0.17 |
RXRX -1.00 |
AFMD -1.00 |
CWBR -1.00 |
HEPA -1.00 |
CNSP -1.00 |
RLAY -1.00 |
INZY -1.00 |
FRLN -1.00 |
SANA -1.00 |
OCEA -1.00 |
DAWN -1.00 |
EFTR -1.00 |
ENVB -1.00 |
ABOS -1.00 |
ABSI -1.00 |
IMMX -1.00 |
Long Term Debt to Equity | 0.14 | 6/18 | XFOR} 0.79 |
INZY} 0.51 |
AFMD} 0.35 |
SANA} 0.29 |
EFTR} 0.22 |
RXRX} 0.14 |
ABOS} 0.14 |
FRLN} 0.06 |
IMMX} 0.06 |
RLAY} 0.05 |
ABSI} 0.03 |
CWBR} 0.00 |
AVRO} 0.00 |
HEPA} 0.00 |
CNSP} 0.00 |
OCEA} 0.00 |
DAWN} 0.00 |
ENVB} 0.00 |
Debt to Equity | 0.17 | 6/18 | EFTR 23.15 |
XFOR 0.83 |
AFMD 0.75 |
INZY 0.57 |
SANA 0.33 |
RXRX 0.17 |
ABOS 0.14 |
FRLN 0.13 |
RLAY 0.06 |
ABSI 0.06 |
IMMX 0.06 |
CNSP 0.01 |
CWBR 0.00 |
AVRO 0.00 |
DAWN 0.00 |
ENVB 0.00 |
OCEA -0.13 |
HEPA -5.47 |
Burn Rate | 4.16 | 2/18 | AVRO 13.22 |
RXRX 4.16 |
IMMX 2.73 |
FRLN 2.31 |
SANA 1.92 |
RLAY 1.67 |
ENVB 1.49 |
CWBR 1.43 |
ABSI 1.32 |
CNSP 1.24 |
EFTR 1.14 |
ABOS 1.07 |
INZY 0.90 |
AFMD 0.40 |
HEPA 0.28 |
OCEA 0.00 |
XFOR -1.68 |
DAWN -11.45 |
Cash to Cap | 0.13 | 15/18 | AVRO 17.33 |
CWBR 5.20 |
XFOR 1.84 |
CNSP 1.21 |
FRLN 1.04 |
ENVB 1.02 |
HEPA 0.70 |
AFMD 0.53 |
ABOS 0.40 |
IMMX 0.36 |
DAWN 0.35 |
INZY 0.28 |
RLAY 0.24 |
SANA 0.20 |
RXRX 0.13 |
ABSI 0.07 |
OCEA 0.00 |
EFTR |
CCR | 0.64 | 11/18 | CNSP 1.21 |
AVRO 1.11 |
INZY 1.00 |
SANA 0.93 |
RLAY 0.85 |
ABOS 0.83 |
EFTR 0.82 |
ABSI 0.76 |
AFMD 0.74 |
FRLN 0.72 |
RXRX 0.64 |
IMMX 0.60 |
HEPA 0.52 |
ENVB 0.44 |
CWBR 0.42 |
OCEA 0.16 |
DAWN -0.13 |
XFOR -0.33 |
EV to EBITDA | -29.11 | 18/18 | DAWN} 27.10 |
FRLN} -0.24 |
XFOR} -0.33 |
CWBR} -1.00 |
AVRO} -1.00 |
HEPA} -1.00 |
CNSP} -1.00 |
INZY} -1.00 |
SANA} -1.00 |
OCEA} -1.00 |
EFTR} -1.00 |
ENVB} -1.00 |
ABOS} -1.00 |
IMMX} -1.00 |
AFMD} -1.54 |
RLAY} -5.47 |
ABSI} -22.91 |
RXRX} -29.11 |
EV to Revenue | 43.93 | 3/18 | ABSI 130.00 |
RLAY 52.65 |
RXRX 43.93 |
DAWN 27.86 |
AFMD 23.05 |
XFOR 19.83 |
FRLN 4.53 |
CWBR -1.00 |
AVRO -1.00 |
HEPA -1.00 |
CNSP -1.00 |
INZY -1.00 |
SANA -1.00 |
OCEA -1.00 |
EFTR -1.00 |
ENVB -1.00 |
ABOS -1.00 |
IMMX -1.00 |